JPY 891.0
(0.34%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 807.98 Million JPY | -37.78% |
2022 | 1.74 Billion JPY | 7.36% |
2021 | 1.62 Billion JPY | 31.41% |
2020 | 1.23 Billion JPY | -12.24% |
2019 | 1.38 Billion JPY | -9.22% |
2018 | 1.56 Billion JPY | 2.87% |
2017 | 1.4 Billion JPY | -6.56% |
2016 | 1.63 Billion JPY | -0.66% |
2015 | 2.04 Billion JPY | 3.85% |
2014 | 1.56 Billion JPY | 13.64% |
2013 | 1.39 Billion JPY | 15.6% |
2012 | 1.19 Billion JPY | 23.51% |
2011 | 959.41 Million JPY | 26.42% |
2010 | 709.96 Million JPY | 2.52% |
2009 | 687.54 Million JPY | 33.72% |
2008 | 570.65 Million JPY | 4.65% |
2007 | 531.9 Million JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 133.5 Million JPY | -43.43% |
2024 Q1 | 236 Million JPY | -26.32% |
2023 Q3 | 241.63 Million JPY | 79.61% |
2023 Q2 | 134.53 Million JPY | -31.41% |
2023 Q1 | 196.13 Million JPY | -50.23% |
2023 FY | - JPY | -37.78% |
2023 Q4 | 314.62 Million JPY | 30.21% |
2022 Q4 | 394.1 Million JPY | 9.85% |
2022 FY | - JPY | 7.36% |
2022 Q1 | 211.36 Million JPY | -32.81% |
2022 Q2 | 388.82 Million JPY | 83.96% |
2022 Q3 | 358.78 Million JPY | -7.73% |
2021 Q2 | 296.1 Million JPY | 29.83% |
2021 Q1 | 228.08 Million JPY | -13.07% |
2021 Q3 | 420 Million JPY | 41.84% |
2021 FY | - JPY | 31.41% |
2021 Q4 | 314.59 Million JPY | -25.1% |
2020 Q4 | 262.36 Million JPY | -23.64% |
2020 FY | - JPY | -12.24% |
2020 Q3 | 343.57 Million JPY | 33.03% |
2020 Q2 | 258.27 Million JPY | 1970.07% |
2020 Q1 | -13.81 Million JPY | -104.19% |
2019 Q3 | 340.48 Million JPY | 14.94% |
2019 Q1 | 159.98 Million JPY | -72.24% |
2019 Q4 | 329.32 Million JPY | -3.28% |
2019 FY | - JPY | -9.22% |
2019 Q2 | 296.23 Million JPY | 85.17% |
2018 FY | - JPY | 2.87% |
2018 Q4 | 576.28 Million JPY | 111.06% |
2018 Q3 | 273.04 Million JPY | 23.31% |
2018 Q2 | 221.43 Million JPY | -15.15% |
2018 Q1 | 260.97 Million JPY | 4.31% |
2017 Q4 | 250.19 Million JPY | -21.76% |
2017 Q1 | 526 Million JPY | 40.95% |
2017 FY | - JPY | -6.56% |
2017 Q3 | 319.75 Million JPY | 34.22% |
2017 Q2 | 238.23 Million JPY | -54.71% |
2016 FY | - JPY | -0.66% |
2016 Q3 | 418.67 Million JPY | 34.02% |
2016 Q4 | 373.18 Million JPY | -10.87% |
2016 Q1 | 369.24 Million JPY | -24.39% |
2016 Q2 | 312.4 Million JPY | -15.39% |
2015 Q4 | 488.32 Million JPY | 16.04% |
2015 FY | - JPY | 3.85% |
2015 Q1 | 278.11 Million JPY | -30.19% |
2015 Q2 | 312.21 Million JPY | 12.26% |
2015 Q3 | 420.82 Million JPY | 34.79% |
2014 Q4 | 398.41 Million JPY | 16.17% |
2014 Q1 | 353.28 Million JPY | 28.66% |
2014 FY | - JPY | 13.64% |
2014 Q3 | 342.94 Million JPY | -4.79% |
2014 Q2 | 360.18 Million JPY | 1.95% |
2013 Q4 | 274.59 Million JPY | -22.11% |
2013 FY | - JPY | 15.6% |
2013 Q3 | 352.53 Million JPY | 5.44% |
2013 Q2 | 334.34 Million JPY | 1.32% |
2013 Q1 | 330 Million JPY | 45.9% |
2012 Q4 | 226.18 Million JPY | 158.75% |
2012 FY | - JPY | 23.51% |
2012 Q3 | -384.99 Million JPY | -161.01% |
2012 Q1 | 636.23 Million JPY | 162.86% |
2012 Q2 | 630.97 Million JPY | -0.83% |
2011 Q1 | 567.31 Million JPY | 100.71% |
2011 Q2 | 531.07 Million JPY | -6.39% |
2011 Q4 | -1.01 Billion JPY | -227.98% |
2011 Q3 | 790.84 Million JPY | 48.92% |
2011 FY | - JPY | 26.42% |
2010 Q1 | 138.73 Million JPY | -28.44% |
2010 Q3 | 239.51 Million JPY | 133.11% |
2010 Q4 | 282.65 Million JPY | 18.01% |
2010 FY | - JPY | 2.52% |
2010 Q2 | 102.74 Million JPY | -25.94% |
2009 Q2 | 173.6 Million JPY | -1.58% |
2009 Q4 | 193.87 Million JPY | -3.29% |
2009 FY | - JPY | 33.72% |
2009 Q3 | 200.47 Million JPY | 15.48% |
2009 Q1 | 176.39 Million JPY | -17.48% |
2008 FY | - JPY | 4.65% |
2008 Q2 | 89.59 Million JPY | 0.0% |
2008 Q4 | 213.75 Million JPY | 52.38% |
2008 Q3 | 140.27 Million JPY | 56.56% |
2007 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Seikagaku Corporation | 2.09 Billion JPY | 61.451% |
Eiken Chemical Co., Ltd. | 5.7 Billion JPY | 85.837% |
Create Medic Co., Ltd. | 1.39 Billion JPY | 41.93% |
PHC Holdings Corporation | 39.08 Billion JPY | 97.933% |
Techno Medica Co., Ltd. | 1.95 Billion JPY | 58.633% |
Rion Co., Ltd. | 4.37 Billion JPY | 81.539% |
Nihon Kohden Corporation | 23.44 Billion JPY | 96.554% |
Fukuda Denshi Co., Ltd. | 36.23 Billion JPY | 97.77% |
Japan Lifeline Co., Ltd. | 12.39 Billion JPY | 93.479% |
Japan Medical Dynamic Marketing, INC. | 3.27 Billion JPY | 75.316% |
3-D Matrix, Ltd. | 2.09 Billion JPY | 61.377% |
CYBERDYNE Inc. | -2 Million JPY | 40499.2% |